» Articles » PMID: 20398135

American Tegumentary Leishmaniasis in Older Adults: 44 Cases Treated with an Intermittent Low-dose Antimonial Schedule in Rio De Janeiro, Brazil

Citing Articles

Self-reporting of hearing loss and tinnitus in the diagnosis of ototoxicity by meglumine antimoniate in patients treated for American tegumentary Leishmaniasis.

Duarte C, Torraca T, Bezerra D, Oliveira R, Leite N, Oliveira R PLoS One. 2024; 19(2):e0296728.

PMID: 38354178 PMC: 10866496. DOI: 10.1371/journal.pone.0296728.


Cutaneous leishmaniasis treatment and therapeutic outcomes in special populations: A collaborative retrospective study.

Castro M, Rode J, Machado P, Llanos-Cuentas A, Hueb M, Cota G PLoS Negl Trop Dis. 2023; 17(1):e0011029.

PMID: 36689465 PMC: 9894540. DOI: 10.1371/journal.pntd.0011029.


An old drug and different ways to treat cutaneous leishmaniasis: Intralesional and intramuscular meglumine antimoniate in a reference center, Rio de Janeiro, Brazil.

Oliveira-Ribeiro C, Pimentel M, Oliveira L, Vasconcellos E, Conceicao-Silva F, Schubach A PLoS Negl Trop Dis. 2021; 15(9):e0009734.

PMID: 34555016 PMC: 8491910. DOI: 10.1371/journal.pntd.0009734.


The Binomial Parasite-Host Immunity in the Healing Process and in Reactivation of Human Tegumentary Leishmaniasis.

Conceicao-Silva F, Leite-Silva J, Morgado F Front Microbiol. 2018; 9:1308.

PMID: 29971054 PMC: 6018218. DOI: 10.3389/fmicb.2018.01308.


Low dose systemic or intralesional meglumine antimoniate treatment for American tegumentary leishmaniasis results in low lethality, low incidence of relapse, and low late mucosal involvement in a referral centre in Rio de Janeiro, Brazil (2001-2013).

Brahim L, Valete-Rosalino C, de Fatima Antonio L, Pimentel M, Lyra M, Paes L Mem Inst Oswaldo Cruz. 2017; 112(12):838-843.

PMID: 29211245 PMC: 5719553. DOI: 10.1590/0074-02760160478.